Takeda Pharmaceutical Co Ltd (TAK)
13.62
+0.06
(+0.41%)
USD |
NYSE |
Nov 15, 16:00
13.62
0.00 (0.00%)
After-Hours: 18:46
Takeda Pharmaceutical Price to Book Value: 0.8914 for Nov. 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 0.8878 |
| November 13, 2024 | 0.8871 |
| November 12, 2024 | 0.8858 |
| November 11, 2024 | 0.893 |
| November 08, 2024 | 0.9015 |
| November 07, 2024 | 0.9068 |
| November 06, 2024 | 0.9022 |
| November 05, 2024 | 0.9303 |
| November 04, 2024 | 0.9192 |
| November 01, 2024 | 0.9133 |
| October 31, 2024 | 0.912 |
| October 30, 2024 | 0.9087 |
| October 29, 2024 | 0.9061 |
| October 28, 2024 | 0.8898 |
| October 25, 2024 | 0.8878 |
| October 24, 2024 | 0.9028 |
| October 23, 2024 | 0.9068 |
| October 22, 2024 | 0.9244 |
| October 21, 2024 | 0.9257 |
| October 18, 2024 | 0.9375 |
| October 17, 2024 | 0.9329 |
| October 16, 2024 | 0.9212 |
| October 15, 2024 | 0.9192 |
| October 14, 2024 | 0.9382 |
| October 11, 2024 | 0.9356 |
| Date | Value |
|---|---|
| October 10, 2024 | 0.9362 |
| October 09, 2024 | 0.9342 |
| October 08, 2024 | 0.9356 |
| October 07, 2024 | 0.9375 |
| October 04, 2024 | 0.9441 |
| October 03, 2024 | 0.9316 |
| October 02, 2024 | 0.9369 |
| October 01, 2024 | 0.9342 |
| September 30, 2024 | 0.9303 |
| September 27, 2024 | 0.9511 |
| September 26, 2024 | 0.9583 |
| September 25, 2024 | 0.9537 |
| September 24, 2024 | 0.9681 |
| September 23, 2024 | 0.974 |
| September 20, 2024 | 0.9681 |
| September 19, 2024 | 0.9766 |
| September 18, 2024 | 0.9694 |
| September 17, 2024 | 0.9714 |
| September 16, 2024 | 0.9681 |
| September 13, 2024 | 0.9616 |
| September 12, 2024 | 0.9694 |
| September 11, 2024 | 0.9694 |
| September 10, 2024 | 0.974 |
| September 09, 2024 | 0.9733 |
| September 06, 2024 | 0.9688 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8228
Minimum
Jun 21 2024
1.457
Maximum
Nov 19 2019
1.065
Average
1.015
Median
Jun 27 2023
Price to Book Value Benchmarks
| HUTCHMED (China) Ltd | 3.868 |
| Astellas Pharma Inc | 1.788 |
| Nxera Pharma Co Ltd | 1.689 |
| PeptiDream Inc | 6.033 |
| Healios KK | 6.707 |
Price to Book Value Related Metrics
| PE Ratio | 22.54 |
| PS Ratio | 1.439 |
| PEG Ratio | 0.6240 |
| Price to Free Cash Flow | 12.61 |
| Price | 13.62 |
| Earnings Yield | 4.44% |
| Market Cap | 43.20B |
| PEGY Ratio | 0.5548 |
| Operating PE Ratio | 13.84 |
| Normalized PE Ratio | 22.54 |